JP2014533241A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533241A5
JP2014533241A5 JP2014539111A JP2014539111A JP2014533241A5 JP 2014533241 A5 JP2014533241 A5 JP 2014533241A5 JP 2014539111 A JP2014539111 A JP 2014539111A JP 2014539111 A JP2014539111 A JP 2014539111A JP 2014533241 A5 JP2014533241 A5 JP 2014533241A5
Authority
JP
Japan
Prior art keywords
patent document
application publication
patent application
insulin
prior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014539111A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/062423 external-priority patent/WO2013063572A1/en
Publication of JP2014533241A publication Critical patent/JP2014533241A/ja
Publication of JP2014533241A5 publication Critical patent/JP2014533241A5/ja
Pending legal-status Critical Current

Links

JP2014539111A 2011-10-27 2012-10-29 超濃縮速効型インスリン類似体製剤 Pending JP2014533241A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552246P 2011-10-27 2011-10-27
US61/552,246 2011-10-27
PCT/US2012/062423 WO2013063572A1 (en) 2011-10-27 2012-10-29 Ultra-concentrated rapid-acting insulin analogue formulations

Publications (2)

Publication Number Publication Date
JP2014533241A JP2014533241A (ja) 2014-12-11
JP2014533241A5 true JP2014533241A5 (enExample) 2015-12-17

Family

ID=48168643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539111A Pending JP2014533241A (ja) 2011-10-27 2012-10-29 超濃縮速効型インスリン類似体製剤

Country Status (10)

Country Link
US (1) US9908925B2 (enExample)
EP (1) EP2771026A4 (enExample)
JP (1) JP2014533241A (enExample)
KR (1) KR20150021011A (enExample)
CN (1) CN104010652A (enExample)
AU (1) AU2012328407A1 (enExample)
BR (1) BR112014010139A2 (enExample)
IN (1) IN2014CN03888A (enExample)
SG (1) SG11201401835VA (enExample)
WO (1) WO2013063572A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015005662A (es) * 2012-11-05 2015-08-20 Univ Case Western Reserve Analogos de insulina de una sola cadena de larga accion.
WO2015106269A2 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
CA2964918A1 (en) * 2014-10-20 2016-04-28 Case Western Reserve University Halogenated insulin analogues of enhanced biological potency
SG10201809457YA (en) * 2014-11-21 2018-11-29 Merck Sharp & Dohme Insulin receptor partial agonists
WO2016105545A2 (en) * 2014-12-24 2016-06-30 Case Western Reserve University Insulin analogues with enhanced stabilized and reduced mitogenicity
WO2017032795A1 (en) 2015-08-25 2017-03-02 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
CA2996455A1 (en) 2015-08-25 2017-03-02 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
EP3341402A1 (en) 2015-08-25 2018-07-04 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
WO2017070617A1 (en) * 2015-10-21 2017-04-27 Case Western Reserve University Diol-modified insulin analogues containing a glucose-regulated conformational switch
SG11201803911PA (en) 2015-12-23 2018-07-30 Univ Case Western Reserve Encapsulation of ultra-stable insulin analogues with polymer melts
SG11202106168VA (en) * 2018-12-11 2021-07-29 Sanofi Sa Insulin analogs having reduced insulin receptor binding affinity
FI4073097T3 (fi) 2019-12-11 2024-08-13 Novo Nordisk As Uusia insuliinianalogeja ja niiden käyttötapoja
WO2024194897A1 (en) * 2023-03-22 2024-09-26 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) A glycation resistant insulin polypeptide and a method of preparing the same thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
ATE93238T1 (de) 1988-07-20 1993-09-15 Novo Nordisk As Menschliche insulinanalage und zubereitungen daraus.
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US20030104981A1 (en) * 1995-11-03 2003-06-05 Jelena Mandic Human insulin analogues
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
US7317000B2 (en) 2001-12-02 2008-01-08 Novo Nordisk A/S Glucose-dependent insulins
WO2003048195A2 (en) 2001-12-02 2003-06-12 Novo Nordisk A/S Glucose dependant release of insulin from glucose sensing insulin derivatives
RU2005131429A (ru) * 2003-03-11 2006-05-10 Ново Нордиск А/С (DK) Фармацевтические препараты, включающие кислотно-стабилизированный инсулин
SE0401942D0 (sv) 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
US20100298213A1 (en) 2004-08-20 2010-11-25 Novo Nordisk A/S Pharmaceutically Active Insulin Receptor-Modulating Molecules
ES2554773T3 (es) * 2006-10-04 2015-12-23 Case Western Reserve University Insulina y análogos de la insulina resistentes a la fibrilación
US8946148B2 (en) 2007-11-20 2015-02-03 Ambrx, Inc. Modified insulin polypeptides and their uses
KR20110061552A (ko) * 2008-07-31 2011-06-09 케이스 웨스턴 리저브 유니버시티 할로겐 안정화된 인슐린
KR20120129875A (ko) * 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
WO2010080606A1 (en) * 2008-12-19 2010-07-15 Indiana University Research And Technology Corporation Insulin analogs

Similar Documents

Publication Publication Date Title
JP2014533241A5 (enExample)
JP2014519662A5 (enExample)
JP2014513484A5 (enExample)
JP2013517798A5 (enExample)
JP2014525291A5 (enExample)
CY1120030T1 (el) Διπλοι glp1/gip ή τριγωνικοι αγωνιστες glp1/gip/ γλυκαγονης
JP2014521827A5 (enExample)
JP2013540292A5 (enExample)
JP2014532727A5 (enExample)
JP2014520155A5 (enExample)
JP2016153424A5 (enExample)
JP2013519136A5 (enExample)
JP2016506366A5 (enExample)
JP2016513069A5 (enExample)
EA201490419A1 (ru) Соединения для лечения и профилактики респираторного синцитиального вирусного заболевания
JP2013539454A5 (enExample)
JP2014509874A5 (enExample)
JP2013214010A5 (enExample)
JP2014520090A5 (enExample)
JP2013532130A5 (enExample)
JP2014502322A5 (enExample)
JP2016506003A5 (enExample)
JP2012094862A5 (enExample)
JP2014508098A5 (enExample)
JP2013515494A5 (enExample)